ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

HZNP Horizon Therapeutics Public Limited Company

116.30
0.00 (0.00%)
Feb 29 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 116.31
Ask Price 116.30
News -
Day High

Low
90.56

52 Week Range

High
116.38

Day Low
Share Name Share Symbol Market Stock Type
Horizon Therapeutics Public Limited Company HZNP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 116.30 18:00:00
Open Price Low Price High Price Close Price Previous Close
116.30 116.30
Trades Shares Traded Average Volume 52 Week Range
0 0 - 90.56 - 116.38
Last Trade Type Quantity Price Currency
- 0 US$ 116.30 USD

Horizon Therapeutics Public Limited Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 26.63B - - - 52.34
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Horizon Therapeutics Pub... News

Date Time Source News Article
10/16/202315:44Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section..
10/09/202306:33IH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers,..
10/06/202317:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202317:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202317:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202317:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202317:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202316:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/06/202315:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in..
10/06/202315:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HZNP Message Board. Create One! See More Posts on HZNP Message Board See More Message Board Posts

Historical HZNP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months115.70116.38114.75115.704,540,3660.600.52%
1 Year109.49116.3890.56108.182,391,0406.816.22%
3 Years91.785120.53557.8496.622,202,03124.5226.71%
5 Years29.11120.53522.6977.292,097,55887.19299.52%

Horizon Therapeutics Pub... Description

Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company has two reportable segments: orphan and inflammation. Orphan segment consists of medicines such as TEPEZZA, KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, UPLIZNA, BUPHENYL, and QUINSAIR. Inflammation segment consists of PENNSAID 2%, DUEXIS, RAYOS, and VIMOVO. It generates the vast majority of its revenue from the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com